Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Book Review
Case Report
Case Series
Editorial
JISH Reviewers List
Letter to the Editor
Media and news
Obituary
Original Article
Pilot Research Projects/Observational Studies
Policy Paper on Homoeopathic Education
Policy Paper on Homoeopathic Education/Research/Clinical Training
Proceedings of Scientific Conferences and Research Meets
Review Article
Systematic Review and Meta-analysis
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Book Review
Case Report
Case Series
Editorial
JISH Reviewers List
Letter to the Editor
Media and news
Obituary
Original Article
Pilot Research Projects/Observational Studies
Policy Paper on Homoeopathic Education
Policy Paper on Homoeopathic Education/Research/Clinical Training
Proceedings of Scientific Conferences and Research Meets
Review Article
Systematic Review and Meta-analysis
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Book Review
Case Report
Case Series
Editorial
JISH Reviewers List
Letter to the Editor
Media and news
Obituary
Original Article
Pilot Research Projects/Observational Studies
Policy Paper on Homoeopathic Education
Policy Paper on Homoeopathic Education/Research/Clinical Training
Proceedings of Scientific Conferences and Research Meets
Review Article
Systematic Review and Meta-analysis
View/Download PDF

Translate this page into:

Case Report
8 (
2
); 80-87
doi:
10.25259/JISH_36_2024

An insight into adolescent polycystic ovarian syndrome and its management with homoeopathy – A case report

Director In Charge, National Institute of Homoeopathy, Kolkata, West Bengal, India.
Department of Paediatrics, National Institute of Homoeopathy, Kolkata, West Bengal, India.
Research Associate, National Institute of Homoeopathy, Kolkata, West Bengal, India.

*Corresponding author: Dr. Vaishnavi Achrekar, Department of Paediatrics, National Institute of Homoeopathy, Kolkata, West Bengal, India. achrekar.vaishnavi@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Sharma P, Achrekar V, Purkait R. An insight into adolescent polycystic ovarian syndrome and its management with homoeopathy – A case report. J Intgr Stand Homoeopathy. 2025;8:80-7. doi: 10.25259/JISH_36_2024

Abstract

Polycystic ovarian syndrome (PCOS) is one of the most common disorders seen in females, with an incidence of 1.55 million cases in the reproductive age group. In recent times, however, the incidence of PCOS has been on the rise in the adolescent age group. In the adult age group, hormonal imbalance and familial medical history play a major part in the development of PCOS in addition to a sedentary lifestyle; however, the pathophysiology in adolescent age is less known. Treatment modalities in the conventional line of treatment have ever-changing guidelines due to difficulty in differentiating PCOS in adolescents from expected pubertal menstrual irregularities. Here, we present a case of an 11-year-old with complaints of irregular menstruation, hirsutism, and acanthosis nigricans – features of adolescent PCOS. The changes in ovarian morphology were monitored using ultrasonography (USG) imaging. The patient’s subjective assessment was evaluated using the validated Outcome Related to Impact on Daily Living (ORIDL) scale. The Modified Naranjo Criteria for Homeopathy (MONARCH) were used to determine the possible causal attribution of the treatment provided. The case remarkably improved on the ORIDL scale (+3). The case was entirely resolved, with improvement evident in ultrasonographic imaging. MONARCH score (+8) established that the likelihood of improvement was attributable to homoeopathy. This case report shows the scope of homoeopathy in cases of PCOS in adolescence and proves the utility of homoeopathy in preventing long-term complications associated with PCOS.

Keywords

Adolescent polycystic ovarian syndrome
Case report
Homoeopathy
Hyperandrogenism
Pulsatilla nigricans

INTRODUCTION

Classical polycystic ovarian syndrome (PCOS) is also known as Stein–Leventhal Syndrome.[1] The classic features of PCOS include chronic anovulation associated with relative infertility, polycystic ovarian morphology, and hirsutism. The adolescent onset PCOS is a relatively newer diagnosis with confusion in the diagnostic criteria as there may be overlapping in normal pubertal development and characteristic features of PCOS.[2] As of now, there are no definitive parameters for diagnosis and treatment of adolescent PCOS. The prevalence in the adolescent age group was studied and came around 11.04%[3]. As per the study conducted in Southern India found the incidence to be 6.8% whereas a systematic review gave a prevalence of 17.74%.[4,5] Lifestyle changes[6] form a solid ground for recovery from PCOS, which includes weight loss and physical exercise. It is associated with significant lowering of testosterone levels and an increase in sex hormone-binding globulin (SHBG) and helps in regulating menstrual irregularities with absolutely no side effects as compared to conventional medications. It also causes significant risk reduction in cardiovascular diseases such as hypertension, dyslipidaemia and glucose intolerance. Treatment modalities in the conventional line of treatment include combined oral contraceptive pills as the first line of treatment in adolescents. The oestrogen part influences increasing SHBG and reducing luteinising hormone, which leads to a reduction of the free androgen index. The progestin component allows for the suppression of endometrial proliferation and regular withdrawal bleeding. It also has an effect in reducing acne and hirsutism.[6] Cyproterone acetate, an efficient and potent progestin with antiandrogenic activity, is one of the other therapy options. However, using this progestin carries a risk of hepatotoxicity and meningioma.[7]

Adolescents who suffer from PCOS are seen to have a lower quality of life when compared with healthy adolescents.[8] Along with compromised metabolic and reproductive aspects, individuals are at a greater risk for depression and stress. The main factor cited as contributing to adolescent depression and mental stress is obesity.[9]

Homoeopathy has been useful in the treatment of diseases of mankind for a long time. There is very little evidence available with respect to the treatment of cases of adolescent PCOS,[10] although homoeopathy has shown good results in treating PCOS in adults.[11-13] Homoeopathic literature is comprehensive with various medicines for ovarian pathologies.[14,15] In this case report, subjective and objective evidence with improved quality of life was documented. This case report follows the HOM-CASE Guidelines.[16]

CASE REPORT

A 11-year-old, Bengali female child studying in 5th standard was brought to the outpatient department of our hospital with the complains of with irregular menstruation since the menarche (Age-10-year old). She has been having irregular menstruation along with which she had been suffering from severe pain in the abdomen during menstruation. Flow was very scanty and dark in colour. The patient was having thick clotted menstrual flow and the menses were much delayed, appearing once every 6 months, all of which is suggestive of oligo-ovulation. Pain was bearing down in nature with pain in her legs. Leucorrhoea appears instead of menses in other months. It was acrid in nature and corroded the under garments. Weakness and nausea were the associated symptoms.

From history, she had suffered from mumps at the age of 4 years. Nothing particular in her family history was noted.

Clinical findings

The patient weighed 50 kg and her height was measured at 140 cm. The patient’s body mass index (BMI) fell within the overweight criteria (25.5 kg/m2). There was no pallor, cyanosis or icterus detected on physical examination.

The patient was a non-vegetarian and could not tolerate hunger. It generally aggravates her complaints. She had a desire for sour things and milk, meat, etc., but not much cravings. There was a generalised aggravation from sun heat as well as sweating. Sweat was profuse and offensive. She was a hot patient. She is very obstinate and headstrong. While weeping, if consolation is provided feels better. She had a fear of ghosts and frequently dreamt of dead bodies.

The patient had increased hair growth over the face, especially on the chin, along with dark, velvety discoloration in the neck region.

Diagnostic assessment

The patient was diagnosed with polycystic ovarian syndrome (2023 ICD-10-CM code is: E28.2)

Reasons:

  1. USG findings suggest polycystic ovaries. [Figure 1]

  2. As per Rotterdam 2003 revised criteria,[17] the patient fulfilled all the three conditions required for the diagnosis of PCOS that are as follows: oligoovulation, hyperandrogenism and polycystic ovaries on USG.

(a) Ultra Sonography. (a) Before. (b) After.
Figure 1:
(a) Ultra Sonography. (a) Before. (b) After.

Therapeutic intervention

The selected homoeopathic medicine was administered orally. The potency, dosage and repetitions were made at the discretion of the physician.

The repertorisation sheet (Synthesis Homoeopathic Repertory Software, Version 2.1.7) considered for the prescription is shown in Figure 2.

Repertorisation chart.
Figure 2:
Repertorisation chart.

Prescription

A single dose of Pulsatilla nigricans 200CH in milk was prescribed, followed by a Placebo, for 30 days. The patient was to take a nutritious diet and make lifestyle changes.

Basis of prescription

From the reportorial analysis, Pulsatilla nigricans was found to be the first indicated medicine by obtaining the highest score (8/17) on repertorisation [Figure 2]. Considering the reportorial totality and based on the other presenting features (thermally hot, mild nature, history of mumps in childhood) the homoeopathic medicine- Pulsatilla nigricans was considered. The main indication was also the time of onset of complaints being at the time of puberty, which is the keynote of Pulsatilla nigricans. After consultation with Materia Medica,[14,15] Pulsatilla nigricans were selected for the final prescription.

Follow-up and outcome

The details of follow-ups are mentioned in Table 1.

Table 1: Timeline for important milestone related to interventions.
Relevant past and family history (symptoms, diagnosis and interventions)
Past history Childhood Mumps, treated allopathically and recovered
Family history Nothing significant
Personal history Nothing significant
Present symptoms/illness Visits Interventions ORIDL
MC OWB
Initial visit
A. Symptoms
Irregular menstruation along with severe pain in the abdomen during menstruation.
Flow was very scanty and dark in colour. Thick clotted flow which appears very late once in 6 months.
B. Physical examination
Patient had increased hair growth over the face especially chin along with dark, velvety discoloration in the neck region. (Acanthosis nigricans)
BMI-25.5 kg/m2
C. Investigations
08 November 2016 -Both ovaries bulky with multiple small cysts. The right and left ovaries measure 4.5*2.3*2.6 cm (Volume-14.5 cc) and 2.7*2.0*5.0 cm (Volume-14.3 cc)
Impression-bilateral polycystic ovarian disease
D. Diagnosis
Polycystic ovarian disease
Visit 01 1 . Pulsatilla nigricans200 CH–1 dose.
To be taken once in morning on empty stomach
2. Placebo 30 dose
To be taken once daily for 30 days
-- --
Summary of follow-up visits
The patient improved further with regular menses, flow gradually improved lasting for up to 5 days. Leucorrhoea also became less and was put on placebo from January 2017 to July 2017
No menses since last 3 months.
Hirsutism better. Dark discoloration over neck present. Leucorrhoea acrid.
Visit 09 1. Pulsatilla nigricans200 CH–1 dose.
To be taken once in morning on empty stomach
2. Placebo 30 dose
To be taken once daily for 30 days
0 +1
No menses in the last 4 months.
Rest symptoms no improvement.
Visit 10 1 . Pulsatilla nigricans1M CH–1 dose
To be taken once in morning on empty stomach
2. Placebo 30 dose
To be taken once daily for 30 days
0 0
Menses appeared, fluid, non-clotted.
Dysmenorrhea.
Hirsutism present.
Dark discoloration reduces
Leucorrhoea present.
Visit 11 Placebo 30 dose
To be taken once daily for 30 days
+1 +2
The patient was improving with regularity of menses and reduced intensity of dysmenorrhoea and was on placebo up to April 2018.
No menstruation since past 2 months.
Hirsutism present.
Dark discoloration-less.
Not remembering LMP.
Visit 18 2. Placebo 30 doses/To be taken once daily for 30 days
Advised for USG of lower abdomen
+1 +1
No menstruation since last 3 months.
Hirsutism present.
Not remembering LMP.
The condition was standstill.
Visit 19 1 . Pulsatilla nigricans1M CH–1 dose
To be taken once in morning on empty stomach
2. Placebo 30 doses
To be taken once daily for 30 days
+1 +1
The patient continued to improve on regularity of menses and reduced intensity of dysmenorrhoea after the dose of Pulsatilla 1M from August 2018 to April 2019 and was put on placebo.
Menses regular.
Headache due to stress during studies. Profuse leucorrhoea with lower abdominal pain occasionally.
Dark discoloration had increased.
Visit 28 1 . Pulsatilla nigricans10M CH–1 dose
To be taken once in morning on empty stomach
2. Placebo 30 doses
To be taken once daily for 30 days
+2 +2
The patient continued with regular menses with slight reduction in intensity of leucorrhoea from August 2019 to August 2020. The patient continued on placebo.
Regular menses, clotted dark and painful.
Leucorrhoea aggravated.
Dark discoloration-Nil.
Hirsutism almost relieved.
Visit 40 1. Pulsatilla nigricans10M CH–1 dose
To be taken once in morning on empty stomach
2. Placebo 30 doses
To be taken once daily for 30 days
+3 +3
The patient improved further from December 2020 to April 2021 as the menses were regular and dysmenorrhoea much less and was continued on placebo
Menses regular. Pain decreased.
Leucorrhoea slightly better but persisting.
Weight-49 kg and
Height-147cm.
BMI reduced to 22.7 kg/m2.
Visit 45 1. Placebo 30 doses/
2. To be taken once daily for 30 days
Advised for USG of lower abdomen
+3 +3
USG (16 September 2021).
Ovaries normal in size shape and echogenicity. No mass or cyst noted
Right ovary-3.6*1.2*2.9 cm, Vol-6.9 cc,
Left ovary-4.4*3.2*1.2 cm, Vol-8.8 cc,

ORIDL: Outcome related to impact on daily living, ORIDL scale: 0: No change/Unsure, +1: Slight improvement, no effect on daily living, +2: Moderate improvement, affecting daily living, +3: Major improvement MC: Main complaints, OWB: Overall wellbeing, CH: Homoeopathic centesimal potency, USG: Ultrasonography, LMP: Last menstrual period, BMI: Body mass index.

Response to the course of treatment

The case showed improvement in remedying the menstrual irregularities as well as in resolution of polycystic ovaries which were detected on USG [Figure 1b]. There was an improvement seen at the level of physical generals with reduction in the overgrowth of hair over face and body. The patient’s weight at end of the treatment measured around 49 kg and height was 147 cm. The BMI reduced to 22.7 kg/m2. The patient showed progressive improvement over a follow-up period of 5 years.

Clinician and patient assessed outcomes

The patient-reported outcome has been measured through the outcome related to impact on daily living (ORIDL) scale.[18] The scale has been widely used for the assessment of improvement of main complaints and the overall well-being of patients based on their subjective experience. After prescribing the individualised homoeopathic medicine, the ORIDL scores [Table 1] were gradually shifted toward positive and ensured (+3) as markedly improved in the case.

Objective evidence

The signs of improvement were systematically documented through USG reports [Figure 1a and b].

Intervention adherence and tolerability

The patient was found to be adherent to the instructions given to her regarding the dosage and time of taking the medicine and complete avoidance of using any other medications from any other system. The patient was advised to have nutritious well-balanced diet. She was instructed to limit oily, fried food. She was asked to undertake moderate exercise on a daily basis to manage her weight.

Adverse or unanticipated events

Throughout the treatment, there were no untoward events classified under adverse drug reactions reported by both the patients as per the existing standard criteria.[19,20]

Homoeopathic aggravation

No homoeopathic aggravation was reported by the patient during the treatment as per the existing criteria.[19,20]

Possible causal attribution

Based on a few listed questions, the Naranjo Criteria algorithm is used to explain the possibility of adverse effects and is linked to pharmacological therapy.[21] The most prominent and well-acknowledged method for evaluating causal attributions is the Naranjo ADR Probability Scale.[22] In this case, the newly developed Modified Naranjo Criteria for Homoeopathy (MONARCH)[23] [Table 1] was used to find out the possible causal attribution between the homeopathic intervention and the clinical improvement of the patients. The high total score (+8 in the −6 to +13 scale) suggested the response favouring homoeopathic intervention.

DISCUSSION

Tackling adolescent PCOS is making a way in unknown waters as it is a tough endocrinological disorder to manage due to unclear knowledge about pathophysiology, diagnostic criteria, and treatment protocols, limited studies being conducted, and difficulty in differentiating it with expected menstrual irregularities in pubertal period. Before diagnosing a case as PCOS with clinical features of androgen excess, such as hirsutism and biochemical hyperandrogenism, it is important to take into account whether oligomenorrhoea has persisted for a minimum of 2 years. If not so, other causes of androgen excess must be ruled out.[2]

The main aim of the treatment lies in establishing regularity of menses with the improvement of other symptoms (acanthosis nigricans, hirsutism and acne). Monitoring changes in USG another way.[24] The other facets that need to be considered by treating physicians are the presence of other medical conditions (Diabetes mellitus, abnormal uterine bleeding and infertility in adults), and psychological issues which also must be managed simultaneously.[25,26]

Treatment protocols available in modern medicine include the use of Oral contraceptive pills alone or along with metformin and antiandrogen agents[27] as per the individual requirement of the study. A study discussed the use of cyproterone acetate and ethinyl oestradiol for long-term in tackling effects of hyperandrogenism. The effects of the above mentioned conventional treatments are not instant but rather must be continued in the patient for a minimum of 6 months or more. A long treatment duration ensures less chance of relapse after the treatment has stopped. Thus, showing the requirement of continuation of treatment for a plausible amount of time even when conventional therapy is considered.[28]

A study conducted on treatment-seeking behaviours in the case of PCOS revealed reasons such as less awareness about the condition, tolerance of disease and high economic burden partly due to investigations and partly due to treatment cost.[29] The annual cost of treatment rounds up to 4.37 billion dollar in United State of America. These costs are considered the initial cost of investigation treatment and the costs are increased with association of diabetes mellitus, hirsutism, abnormal uterine bleeding and infertility. These costs do not include the cost of repeat investigations and cost of lifestyle intervention, which only add on to the previously mentioned economic burden.[30]

The case presented is of an adolescent girl with premature menarche and a classical picture of PCOS. During therapy, the case improved progressively with respect to both disease symptoms and the general health of the patient. The case was managed with individualised homoeopathic medicine with lifestyle changes. Pulsatilla was the drug of choice for the case as it covered the totality of symptoms perfectly.

PCOS is a progressive lifetime disorder if not managed timely with worsening metabolic and physical symptoms. In the adolescent age group, the complaints of acne, hirsutism and obesity have serious implications as it has a grave effect on self-confidence and poor body image of the young girl.[31]

In this case report, improvements were documented through different subjective and objective pieces of evidence. Improvement in the primary complaint and general well-being were assessed using the ORIDL scale at each follow-up visit.[18] The ORIDL score eventually changed to positive (+3), indicating a significant improvement. Unbiased evidence was presented in the form of ultrasonographic findings. MONARCH[23] was utilised to assess the potential cause attributions. The +8 score out of the maximum +13 score in MONARCH [Table 2], in this case, indicates a higher probability of a causal relationship between the homoeopathic intervention and the patient’s clinical improvement.

Table 2: Modified Naranjo Criteria for Homoeopathy.
Domains Yes No Not sure/NA
Was there an improvement in the main symptom or condition for which the homoeopathic medicine was prescribed? +2
Did the clinical improvement occur within a plausible timeframe relative to the medicine intake? -2
Was there a homoeopathic aggravation of symptoms? +1
Did the effect encompass more than the main symptom or condition (i.e. were other symptoms, not related to the main presenting complaint, improved, or changed)? +1
Did overall well-being improve? (Suggest using a validated scale or mention about changes in physical, emotional and behavioural elements) +1
(A) Direction of cure: did some symptoms improve in the opposite order of the development of symptoms of the disease? +1
(B) Direction of cure: did at least two of the following aspects apply to the order of improvement of symptoms:
• From organs of more importance to those of less importance?
• From deeper to more superficial aspects of the individual?
• From the top downwards?
0
Did ‘old symptoms’ (defined as non-seasonal and non-cyclical symptoms that were previously thought to have resolved) reappear temporarily during the course of improvement? +1
Are there alternative causes (i.e. other than the medicine) that – with a high probability – could have produced the improvement? (Consider known course of disease, other forms of treatment and other clinically relevant interventions) +1
Was the health improvement confirmed by any objective evidence? (e.g. investigations, clinical examination, etc.) +2
Did repeat dosing, if conducted, create similar clinical improvement? 0
Total score
(Maximum+13, Minimum -6)
+8

NA: Not applicable, +1/+2/0/-3- are predefined marks for each question separately in the MONARCH criteria itself.

Homoeopathy is a gentle method of treatment based on strict principles of individualisation, which considers ‘the man in sickness’ and not just ‘the disease in man’, ensuring quality treatment is provided to every individual. The case report presented is a classic example of individualised treatment. The economic burden of the disease is much higher as it involves the cost of investigation, treatment and making modifications in lifestyle. Homoeopathy provides an additional benefit as cost of treatment is minimal even if the duration of treatment is of years duration. It also has an advantage of simplicity of treatment which does not involve addition of a greater number of medicines with each additional symptom making it easier for patients to adhere to treatment especially of adolescent age.

The case was followed over a period of 5 years and showed no adverse drug reaction or any untoward complication during the case management. The case also highlights the use of a placebo in homoeopathic practice correctly, as said by Dr. Stuart Close, being ‘the second-best remedy.’[32] The treatment response was monitored mainly symptomatically. The USG findings have shown complete curing of pathology. The duration of treatment was 5 years, thus ensuring the complete removal of disease from the roots and ensuring that no relapse of the condition occurred. The primary limitation of this case report is the very long duration of treatment. The study provided the patient a good result, saving her the stigma of having hirsutism, acanthosis nigricans which can impair the social life of youngsters severely. However, the time involved in complete treatment was very long. The other limitation which can be considered in future is taking up a bigger sample size and demonstrating the effects of homoeopathic treatment thus generating higher levels of evidence. Case reports may be biased by the author’s experiences or beliefs because there are no control groups and few cases. On the other hand, in the field of evidence-based medicine, every level of evidence has considerably and effectively advanced clinical research. This case report’s information has been very useful, and by offering additional examples that are comparable to this one, we will be able to generate a hypothesis that could ultimately lead to more controlled and comprehensive clinical research.

CONCLUSION

The case provides a good insight in management of the case of adolescent PCOS. Homoeopathy as a science does not rely on the diagnosis for management of cases and this can be very well depicted in the case as adolescent PCOS is an unexplored area with respect to knowledge on pathophysiology and treatment protocols. It also depicts the nature and treatment of chronic diseases and how the treatment requires patience on part of a physician as well as patient. It also requires adherence on part of patient to the treatment as well as to diet and regimen changes which must be made in accordance with the disease. This case report necessitates taking up long-term interventional studies in case of polycystic ovarian syndrome with proper methodical rigor.

Ethical approval:

Institutional Review Board approval is not required.

Declaration of patient consent:

The authors certify that they have obtained all appropriate patient consent.

Conflicts of interest:

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation:

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

Financial support and sponsorship: Nil.

References

  1. , . Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;29:181-91.
    [CrossRef] [Google Scholar]
  2. , , , , , , et al. The diagnosis of polycystic ovary syndrome during adolescence. Horm Res Paediatr. 2015;83:377-84.
    [CrossRef] [PubMed] [Google Scholar]
  3. , , , , , , et al. The prevalence of polycystic ovary syndrome in adolescents: A systematic review and meta-analysis. Int J Reprod Biomed. 2019;17:533-42.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , , , , , et al. Polycystic ovarian syndrome: Prevalence, predisposing factors, and awareness among adolescent and young girls of South India. Cureus. 2022;14:e27943.
    [CrossRef] [Google Scholar]
  5. , , , . Polycystic ovary syndrome among Indian adolescent girls-a systematic review and metanalysis. Nepal J Epidemiol. 2021;11:1063-75.
    [CrossRef] [PubMed] [Google Scholar]
  6. , , , , , , et al. An international consortium update: Pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Horm Res Paediatr. 2017;88:371-95.
    [CrossRef] [PubMed] [Google Scholar]
  7. , , , , , . PCOS in adolescents-ongoing riddles in diagnosis and treatment. J Clin Med. 2023;12:1221.
    [CrossRef] [PubMed] [Google Scholar]
  8. , , , . Quality of life in adolescent girls with polycystic ovary syndrome. Arch Pediatr Adolesc Med. 2002;156:556-60.
    [CrossRef] [PubMed] [Google Scholar]
  9. , , . Polycystic ovarian syndrome-related depression in adolescent girls: A review. J Pharm Bioallied Sci. 2018;10:55-9.
    [CrossRef] [PubMed] [Google Scholar]
  10. , , . Polycystic ovarian syndrome treated with individualized homeopathy: A case report. Altern Ther Health Med. 2022;28:60-4.
    [Google Scholar]
  11. , . Potentised black lead in the treatment of polycystic ovarian syndrome: An evidence-based case report. Homœopathic Links. 2022;35:210-3.
    [CrossRef] [Google Scholar]
  12. , . Homeopathic treatment in patients with polycystic ovarian syndrome: A case series. Homeopathy. 2021;110:186-93.
    [CrossRef] [PubMed] [Google Scholar]
  13. , . Homoeopathic management in a case of infertility with PCOS. Homoeopathic Links. 2021;34:148-52.
    [CrossRef] [Google Scholar]
  14. . Keynotes and characteristics with comparisons of some of the leading remedies of the materia medica with bowel nosodes New Delhi: B Jain Publishers Pvt. Ltd.; . p. :235.
    [Google Scholar]
  15. . Pocket manual of homoeopathic materia medica & repertory: Comprising of the characteristic and guiding symptoms of all remedies (clinical and pahtogenetic [sic]) including Indian drugs New Delhi: B Jain Publishers Pvt. Ltd.; . p. :167.
    [Google Scholar]
  16. . Homeopathic clinical case reports: Development of a supplement (HOM-CASE) to the CARE clinical case reporting guideline. Complement Ther Med. 2016;25:78-85.
    [CrossRef] [PubMed] [Google Scholar]
  17. . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod. 2004;19:41-7.
    [CrossRef] [PubMed] [Google Scholar]
  18. , , , . Outcome related to impact on daily living: Preliminary validation of the ORIDL instrument. BMC Health Serv Res. 2007;7:139.
    [CrossRef] [PubMed] [Google Scholar]
  19. , , , , . Risk in homeopathy: Classification of adverse events and homeopathic aggravations--a cross sectional study among Norwegian homeopath patients. Complement Ther Med. 2015;23:535-43.
    [CrossRef] [PubMed] [Google Scholar]
  20. , , . Is it possible to distinguish homeopathic aggravation from adverse effects? A qualitative study. Forsch Komplementmed. 2012;19:13-9.
    [CrossRef] [PubMed] [Google Scholar]
  21. , . Adverse drug reaction-causality assessment. Int J Res Pharm Chem. 2011;1:606-12.
    [Google Scholar]
  22. , , , , , , et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-45.
    [CrossRef] [PubMed] [Google Scholar]
  23. , , , , , , et al. Evaluation of the modified naranjo criteria for assessing causal attribution of clinical outcome to homeopathic intervention as presented in case reports. Homeopathy. 2020;109:191-7.
    [CrossRef] [PubMed] [Google Scholar]
  24. , , , . Homoeopathy a system of holistic healing as an alternative treatment for PCOS-a review. Int J High Dil Res. 2021;20:43-59.
    [CrossRef] [Google Scholar]
  25. , . Polycystic ovary syndrome in adolescence: Diagnostic and therapeutic strategies. Transl Pediatr. 2017;6:248-55.
    [CrossRef] [PubMed] [Google Scholar]
  26. , , . Anxiety and depression in polycystic ovary syndrome: A comprehensive investigation. Fertil Steril. 2010;93:2421-3.
    [CrossRef] [PubMed] [Google Scholar]
  27. , , , . The diagnosis and treatment of PCOS in adolescents: An update. Curr Opin Pediatr. 2019;31:562-9.
    [CrossRef] [PubMed] [Google Scholar]
  28. , . Polycystic ovary syndrome in adolescence--a therapeutic conundrum. Hum Reprod. 2004;19:1039-42.
    [CrossRef] [PubMed] [Google Scholar]
  29. , , , , , , et al. Treatment seeking behavior among patients with polycystic ovarian syndrome (PCOS)-a cross-sectional study from Northern India. J Educ Health Promot. 2023;12:194.
    [CrossRef] [PubMed] [Google Scholar]
  30. , , , , . Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab. 2005;90:4650-8.
    [CrossRef] [PubMed] [Google Scholar]
  31. , , . Quality of life, mental health and self-esteem in hirsute adolescent females. J Psychosom Obstet Gynecol. 2010;31:168-75.
    [CrossRef] [PubMed] [Google Scholar]
  32. . The genius of homoeopathy: Lectures and essays on homoeopathic philosophy In: 12th impression. New Delhi: B Jain Publishers Pvt. Ltd.; . p. :139.
    [Google Scholar]
Show Sections